Advertisement
Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates
From: Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
